Who we are

MMWR Ltd. is a UK R&D company developing novel methods and applications of
Microwave Radiometery (MWR) technology or in vitro, cell assays, pre-clinical, and clinical applications.
Microwave Radiometry Devices can visualise microwave emissions from human body.
The device is non-invasive, passive sensor with noise reduction visualising infrared and microwave emissions from biological objects

Learn more...

AppLICATION

Potential Customers.

GPs for earlier diagnostics
Sport Doctors (boxing, football, rugby, etc.)
Hospitals for treatment control and early diagnostics
Massage and tan cabinets
Physiotherapy
Traditional medicine
Cosmetic clinics

Learn more...

Science

The brain is the most critical organ, controlling all other bodily functions, yet it is one of the least understood and most complex parts of the body.

Gaining a better understanding of the brain unlocks the opportunity for significant medical advances, only some of which we currently understand. CoMind’s technology not only has the power to improve the lives of patients, but it also has the potential to unlock new insights into and understanding of the brain and its functions. This has the potential to change the way we approach brain health and technology, and ultimately, to make a lasting impact on society.

Publications and Press Releases

11 medical device startups to watch, according to investors

CoMind is developing non-invasive neural sensors aiming to enable better assessment and treatment for complex neurological conditions. Often neuroscience and neurosurgical conditions are limited in how they can measure important parameters for clinical management and CoMind addresses this problem.

CoMind Welcomes a New Leader to the Team

CoMind is thrilled to announce the addition of a new leader to the team. Mimosa (“Mo”) Nguyen has been appointed as the Director of People. She will play instrumental roles in the strategic direction of CoMind and our continued growth.

30 Under 30 – Europe – Technology (2022)

James Dacombe, a Thiel Fellow, dropped out of high school at age 16 to work as a software engineer at a startup and then left that to build CoMind at 17. The London-based, neurotechnology startup, which has raised $15 million, aims to develop a neurosensing technology that would catalyze a new wave of neuroscience and neurology applications within medical devices.

Careers

Advancing neural sensing for brain disorder patients globally

Contact us

Leading the next cognitive and computing revolution

Stay in touch

Get regular updates about our latest hires, technical and business milestones, and developments in brain-computer interface technology by subscribing